127 related articles for article (PubMed ID: 34914287)
1. [Bioinformatics-based identification of the key genes associated with prostate cancer].
Zhao HB; Xu GB; Yang WQ; Li XZ; Chen SX; Gan Y; Su ZM; Sheng M; Zeng YR
Zhonghua Nan Ke Xue; 2021 Jun; 27(6):489-498. PubMed ID: 34914287
[TBL] [Abstract][Full Text] [Related]
2. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
3. Identification of the hub genes associated with prostate cancer tumorigenesis.
Zhu H; Lin Q; Gao X; Huang X
Front Oncol; 2023; 13():1168772. PubMed ID: 37251946
[TBL] [Abstract][Full Text] [Related]
4. Discovering Gene Signature Shared by Prostate Cancer and Neurodegenerative Diseases Based on the Bioinformatics Approach.
Su Q; Dai B; Zhang H; Zhang S
Comput Math Methods Med; 2022; 2022():8430485. PubMed ID: 35799671
[TBL] [Abstract][Full Text] [Related]
5. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
6. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
7. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.
Wang Y; Wang J; Tang Q; Ren G
PLoS One; 2021; 16(2):e0247827. PubMed ID: 33630978
[TBL] [Abstract][Full Text] [Related]
8. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
9. Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer.
Alwadi D; Felty Q; Yoo C; Roy D; Deoraj A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834602
[TBL] [Abstract][Full Text] [Related]
10. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
Gu P; Yang D; Zhu J; Zhang M; He X
Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
13. Integrated Network Analysis to Determine CNN1, MYL9, TAGLN, and SORBS1 as Potential Key Genes Associated with Prostate Cancer.
Li C; Pang L; Jin F; Song Y; Zhou D; Song Y; Li Y; Jin S; Zhang L; Liang W; Shen X; Li J; She B; Wang C; Ma L
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436378
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Key Genes in Prostate Cancer with Gene Expression, Pivotal Pathways and Regulatory Networks Analysis Using Integrated Bioinformatics Methods.
Khan MM; Mohsen MT; Malik MZ; Bagabir SA; Alkhanani MF; Haque S; Serajuddin M; Bharadwaj M
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456461
[TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
16. Identification of key genes in prostate cancer gene expression profile by bioinformatics.
Lu W; Ding Z
Andrologia; 2019 Feb; 51(1):e13169. PubMed ID: 30311263
[TBL] [Abstract][Full Text] [Related]
17. Screening and identification of key biomarkers in prostate cancer using bioinformatics.
Li S; Hou J; Xu W
Mol Med Rep; 2020 Jan; 21(1):311-319. PubMed ID: 31746380
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
Foj L; Filella X
Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
[TBL] [Abstract][Full Text] [Related]
19. MYLK and CALD1 as molecular targets in bladder cancer.
Jin H; Liu B; Guo X; Qiao X; Jiao W; Yang L; Song X; Wei Y; Jin T
Medicine (Baltimore); 2023 Nov; 102(47):e36302. PubMed ID: 38013282
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]